Thomas Hardy

Thomas Hardy currently serves as the Chief Medical Officer at Adipo Therapeutics since May 2025. Prior to this role, Thomas held the position of Vice President for Drug Safety and Pharmacovigilance at Immunovant from October 2021 to May 2025. Thomas's extensive experience in the medical field also includes over 18 years at Eli Lilly and Company, where positions included Senior Medical Director and Senior Medical Advisor. Academic credentials include an MD and PhD in Medicine and Biochemistry from Indiana University School of Medicine, complemented by studies at the University of California, Santa Cruz.